NCT03718052View on ClinicalTrials.gov

Early Valve Surgery Versus Conventional Treatment in Infective Endocarditis Patients With High Risk of Embolism

NAActive, not recruitingINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

April 11, 2019

Primary Completion Date

May 31, 2025

Study Completion Date

July 31, 2026

Conditions
Endocarditis
Interventions
PROCEDURE

Early valve surgery (EVS)

Early valve surgery (EVS) within 72 hours of randomization

PROCEDURE

Conventional Care

Conventional care according to the 2015 European guidelines.

Trial Locations (1)

75018

Bichat Claude Bernard Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03718052 - Early Valve Surgery Versus Conventional Treatment in Infective Endocarditis Patients With High Risk of Embolism | Biotech Hunter | Biotech Hunter